￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What changes will occur if you take ensifentrine-Ohtuvayre for three consecutive months?

2026-02-01 22:25:32

Check Details
List of contraindications and side effects of Everolimus/Afinitor

2026-02-01 22:25:32

Check Details
Explore the market price and purchase channels of Anagrelide

2026-02-01 22:25:32

Check Details
Things to note and suggestions when using Atrasentan

2026-02-01 22:25:32

Check Details
The Difference Between Elotuzumab and Elotuzumab

2026-02-01 22:25:32

Check Details
Efficacy and mechanism of action of bimekizumab

2026-02-01 22:25:32

Check Details
Can one box of ensifentrine-Ohtuvayre last for one year?

2026-02-01 22:25:32

Check Details
Common causes and relief measures for general discomfort after taking axitinib (Inlida)

2026-02-01 22:25:32

Check Details
How long should trametinib (Megenin) be taken before discontinuation can be considered and clinical recommendations

2026-02-01 22:25:32

Check Details
Can avatrombopag (Sucoxin) treat thrombocytopenia associated with chronic liver disease?

2026-02-01 22:25:32

Check Details
How many days does the targeted drug Giritinib (Segatan) begin to take effect and the course of treatment is observed

2026-02-01 22:25:32

Check Details
What are the common side effects of Osimertinib (Tagrisso) and how to deal with them

2026-02-01 22:25:32

Check Details
Category
相关知识